Pomegranate: study protocols
3 study groups say how much Pomegranate participants took a day. These are the doses the studies gave. They are not a recommendation.
Dose per serving from products
556 products in our catalogue print how much Pomegranate a serving holds.
Most common: 500 mg to 1 g, 28% of 556 products.
| Dose per serving | Products |
|---|---|
| 10 mg or less | 21 |
| 10 mg to 25 mg | 66 |
| 25 mg to 50 mg | 77 |
| 50 mg to 100 mg | 91 |
| 100 mg to 250 mg | 79 |
| 250 mg to 500 mg | 58 |
| 500 mg to 1 g | 157 |
| over 1 g | 7 |
Fewer than 5 study groups in one unit match, too few to draw the chart.
Commonly used together
2 of 3 study groups took Pomegranate with something else, but nothing that 3 or more different studies gave.
3 study groups
| Study | |||
|---|---|---|---|
| A Randomized, Placebo-Controlled Trial Evaluating Multi-Species Synbiotic Supplementation for Bloating, Gas, and Abdominal Discomfort 2026 · multi-species synbiotic · Generally healthy adult men and women with self-reported bloating/indigestion for at least 3 months and no reported medical diagnosis of a functional GI disorder | 400 mg | 6 weeks | — |
| Pomegranate (Punica granatum L.) peel extract ameliorates metabolic syndrome risk factors in patients with non-alcoholic fatty liver disease: a randomized double-blind clinical trial 2023 · pomegranate peel group · Adults aged 18–60 with non-alcoholic fatty liver disease, liver fibrosis and steatosis; men and women | 1.5 g | 8 weeks | 39 |
| Multi-Species Synbiotic Supplementation Enhances Gut Microbial Diversity, Increases Urolithin A and Butyrate Production, and Reduces Inflammation in Healthy Adults: A Randomized, Placebo-Controlled Trial 2025 · DS-01 multi-species synbiotic · Healthy adults; age range and sex not specified | 400 mg | 13 weeks | 16 |